Dian specialises in the preparation and prosecution of patent applications in the fields of chemistry and pharmaceuticals. She also provides advice on patentability, validity and patent infringement as well as guidance on patent filing strategy.
Dian obtained an honours degree in chemistry and a PhD in organic chemistry from the University of Edinburgh. Her PhD research into the use of reactive intermediates in the field of heterocyclic chemistry was funded by a postgraduate scholarship from BP plc.
Dian joined Davies Collison Cave in 2015 after spending four years with another Australian patent firm where she qualified as an Australian patent attorney. Prior to moving to Australia, she spent 11 years with the intellectual property department of Smithkline Beecham (later GlaxoSmithKline) in the UK where she gained experience in both contentious and non-contentious patent matters and qualified as a European and UK patent attorney.
She has successfully secured patent protection for pharmaceutical products and clinical candidates in most major markets in addition to obtaining patent term extension for marketed pharmaceuticals. She also has experience in contentious matters in several jurisdictions including Eastern Europe, India, Russia and China.
Before embarking on a career as a patent attorney, Dian obtained considerable research experience during 10 years with 3M where she carried out research into novel small molecules for several technology areas including imaging systems and flame retardants. While at 3M, Dian was a named inventor on several patent applications and was awarded the 3M Corp Bond of Excellence, the 3M Circle of Technical Excellence and the 3M UK Outstanding Service Quality Award. She was also a member of a small research team shortlisted for The Royal Society of Chemistry Industrial Innovation Award for their work on a novel imaging system.